Skip to main content
SpringerLink
Log in

Prolonged dynamic clinico-immunological observation of 85 patients with definite multiple sclerosis: First steps towards monitoring process activity

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Prolonged clinico-immunological observation of 85 patients with definite multiple sclerosis (MS) was performed in order to elucidate the connections between the clinical and immune state. A battery of immunological investigations was performed, including estimation of T-cell subpopulations in blood and cerebrospinal fluid (CSF); proliferative responses of circulating lymphocytes to mitogens, recombinant interleukin-2 (rIL2) and myelin basic protein levels in different culture conditions; levels of immunoglobulin (Ig) in sera and CSF, and of Ig production in vitro; indices of IL2 synthesis and IL2 sensitivity; production of prostaglandin E2 and tumour necrosis factor (TNF) alpha by monocytes and levels of β-endorphin in sera and supernatants phytohaemagglutinin of (PHA)-activated cells. Clinical observation was performed periodically using Kurtzke scales and was supplemented by repeated recording of evoked potentials and magnetic resonance imaging. Initial investigations showed specific differences between patients with MS and the control groups (donors and patients with other neurological disorders of the same age). Correlative and regressive analyses showed no association between immunological and clinical parameters at the initial investigation, although immunological indexes were inter-related, and indicated specific alterations in immuno-regulation in MS. Retrospective analysis revealed associations between the clinical status of patients with MS and their previous immune status. Evidence of cell activation — including a decreased percentage of circulating cells with differential antigens, lower cell mitogen-induced proliferative responses in vitro, with restoration following the addition of autoserum, greater IL2 sensitivity, and increased TNF-alpha production by macrophages — often predicted the clinical manifestation of deterioration. It is proposed that the immunopathological process in MS has a number of stages with characteristic features, and that progression from one stage to another can be subclinical. No single immunological index can be used to determine stage. Only systemic alterations reflect the real situation, whilst every patient has some abnormalities. A system of clinico-immunological monitoring could severe as the basis for a new approach to the dynamic treatment of MS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Antel JP, Arnason BGW, Medof ME (1979) Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol 5:338–342

    Google Scholar 

  2. Antel JP, Posenkoetter M, Reder A, Oger JJ-F, Arnason BGW (1984) Multiple sclerosis relation to in vitro IgG secretion to T suppressor cell number and function. Neurology 34:1155–1160

    Google Scholar 

  3. Beck J, Rondol R, Catinof L, Falcoff E, Kirchner H, Wietzerbin J (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis. Acta Neurol Scand 78:318–323

    Google Scholar 

  4. Brajczewska-Fisher W, Iwinska B, Kruszewska J, Korlak J, Czlonkowska A (1989) Interleukin 1 and 2 production by peripheral blood mononuclear cells in subacute sclerosing panencephalitis and exacerbation of multiple sclerosis. Acta Neurol Scand 80:390–393

    Google Scholar 

  5. Deomina TL, Boiko AN, Balashov KJ, Pinegin BV (1989) Peculiarities of MS cellular immunity (in Russian). Korsakov J Neurol Psychiatry 2:35–41

    Google Scholar 

  6. Deomina TL, Boiko AN, Gusev EI, Balaskov KJ (1990) Clinico-immunological correlations, recorded during prolonged dynamic observation of patients with multiple sclerosis (in Russian). Immunology 5:53–57

    Google Scholar 

  7. Deomina TL, Boiko AN, Rossels AN, Balashov KJ, Popova HF (1990) Investigation of cellular immunity and opioid peptides system in patients with multiple sclerosis (in Russian). Korsakov J Neurol Psychiatry 2:19–21

    Google Scholar 

  8. Deomina TL, Boiko AN, Oganezov VK, Ketlinsky SA, Prokopiev AA, Balashov KJ, Pinegin BV (1991) Tumor necrosis factor-alpha participation in immunoregulation in chronic progressive forms of multiple sclerosis (in Russian). Immunology 4:40–42

    Google Scholar 

  9. Fontana L, Fattorissi A, D'Amello R (1987) Modulation of human Con-A-induced lymphocyte proliferative response by physiological concentrations of beta-endorphin. Immunopharmacology 13:111–115

    Google Scholar 

  10. Frey H, Molnar G (1977) Spontaneous and PHA stimulated transformation in multiple sclerosis patients during and after acute exacerbations with special reference to steroid therapy. Acta Neurol Scand 55:443–454

    Google Scholar 

  11. Gills S, Ferm MM, Qu W, Smith KA (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 120:2027–2031

    Google Scholar 

  12. Haller DA, Weiner HL (1989) MS: a CNS and systemic autoimmune disease. Immunol Today 10:104–107

    Google Scholar 

  13. Hofman FM, Hinton DR, Jonson K, Merill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607–612

    Google Scholar 

  14. Hughes PJ, Compston DAS (1988) Peripheral blood lymphocytes phenotype and function in multiple sclerosis. J Neurol Neurosurg Psychiatry 51:1187–1192

    Google Scholar 

  15. Ilonen I, Reunanen M, Salmi A, Herva E (1983) Lymphocyte blast transformation responses to mytogens and specific antigens in different clinical phases of multiple sclerosis: a follow-up study. Acta Neurol Scand 68:1–12

    Google Scholar 

  16. Ilyas AA, Davison AN (1983) Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis. J Neurol Sci 59:85–95

    Google Scholar 

  17. Lassmann H, Waksman B, Brosnan CF (1991) Mechanisms of vascular and tissue damage in demyelinating diseases. J Neuroimmunol 32:83–85

    Google Scholar 

  18. Maimore D, Gregory S, Arnason GW, Reder AT (1991) Cytokine levels in the CSF and serum of patients with MS. J Neuroimmunol 32:67–74

    Google Scholar 

  19. Morimoto C, Hafler DA, Weiner HL, Letvin NL, Hagan M, Daley J, Schlossman SF (1987) Selective loss of the suppressor-inductor T-cell subset in progressive multiple sclerosis. N Engl J Med 316:67–72

    Google Scholar 

  20. Pini C, Afferni C, Dellegrini P, Berghella AM, Adomo P, Lanzi G, Prencipe M, Casciani CU (1987) Identification of factors interacting with a subset of T8+ cells. Riv Neurol 57:20–23

    Google Scholar 

  21. Poser CM, Paty GW, Scheinberg LC (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231

    Google Scholar 

  22. Prencipe M, Sdlerni E, D'Aurizo C, Marini C, Adorno D, Berghella AM, Pellegrini P, Papola F, Casciani CU (1986) T lymphocyte subsets modifications in multiple sclerosis: correlation with clinical disease activity. Ital J Neurol Sci 7:583–587

    Google Scholar 

  23. Oger J, Kastrukoff L, Li GKB, Paty DW (1988) Multiple sclerosis: in relapsing patients immune activity varies with disease activity as assessed by MRI. Neurology 38:1739–1744

    Google Scholar 

  24. Rastogi S, Clausen J (1985) Effect of multiple sclerosis alpha-2-macro-globulin on mitogen induction of lymphocytes proliferation. Immunology 169:339–345

    Google Scholar 

  25. Reunanen MI, Ilonen J, Arnadotti T, Ahonen A, Salmi A (1983) Mitogen and antigen stimulation of multiple sclerosis lymphocytes in vitro. J Neurol Sci 58:211–221

    Google Scholar 

  26. Rice GPA, Finney D, Braheny SL, Knobler RL, Sipe JC, Oldstone MBA (1984) Disease activity markers in multiple sclerosis. Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5 and OKT8. J Neuroimmunol 6:75–84

    Google Scholar 

  27. Rose L, Ginsberg AH, Rothstein TL, Ledbetter JA, Clark EA (1988) Fluctuation of CD4+ T cell subsets in remitting-relapsing multiple sclerosis. Ann Neurol 23:192–199

    Google Scholar 

  28. Ruddle NH (1987) Tumor necrosis factor and related cytotoxins. Immunol Today 5:129–130

    Google Scholar 

  29. Salmaggi A, Bianchi G, Cerrato D, Lazzaroni M, Malesani L, Nespolo A, Corridori F, La Mantia L, Milanese C (1987) Cerebrospinal fluid and peripheral blood T-lymphocyte subsets in multiple sclerosis: monoclonal antibody analysis and correlations with clinical activity. Ital J Neurol Sci 8:327–330

    Google Scholar 

  30. Sandberg Wolheim M (1983) Lymphocyte population in the cerebrospinal fluid and peripheral blood of patients with multiple sclerosis and optic neuritis. Scand J Immunol 17:575–581

    Google Scholar 

  31. Selmaj K, Nowak Z, Tchorzewski H (1988) Interleukin 1 and interleukin 2 production by peripheral blood mononuclear cells in multiple sclerosis patients. J Neurol Sci 85:67–71

    Google Scholar 

  32. Selmaj K, Nowak Z, Tchorzewski H (1988) Multiple sclerosis: effect of myelin basic protein on interleukin l, interleukin 2, production and interleukin 2 receptor expression in vitro. Clin Exp Immunol 572:428–433

    Google Scholar 

  33. Smith EM, Harbour-McMenanin D, Blalock JE (1985) Lymphocyte production of beta-endorphin and endorphin-mediated immunoregulatory activity. J Immunol 135:779–782

    Google Scholar 

  34. Tornier-Lasserve E, Roullet E, Lyoncaen O, Bach MA (1986) Comparison of the response to phytogemagglutinin of peripheral blood mononuclear cells and cerebrospinal fluid lymphocytes in multiple sclerosis and other neurological disorders. Determination of the frequency of the precursor cells by a limiting dilution analysis. Acta Neurol Scand 74:66–71

    Google Scholar 

  35. Trenn G, Kreuzfelder E, Hierholzer E, Scheiermann N, Bauer HJ, Bushart W (1988) Age-associated T-lymphocytes activation through mitogens in patients with multiple sclerosis and blood donors. Eur Neurol 28:47–50

    Google Scholar 

  36. Vervliet G, Schourdent L (1985) In vitro correction of the interleukin 2 and gamma-interferon defect in multiple sclerosis. Clin Exp Immunol 61:556–561

    Google Scholar 

  37. Walker JE, Cook JD (1979) Lymphoblastic transformation in response to viral antigens in multiple sclerosis. Neurology 29:1341–1347

    Google Scholar 

  38. Weiner HL, Ellison GW (1983) A working protocol to be used as a guideline for trials in multiple sclerosis. Arch Neurol 40:704–710

    Google Scholar 

  39. Weiner HL, Hafler DA, Fallis RS, Johnson D, Auli KA, Hauser SL (1984) Altered blood T cell subsets in patients with multiple sclerosis. J Neuroimmunol 6:115–121

    Google Scholar 

  40. Yarram Y, Naparstek Y, Lev-Rami V, Holoshitz J, Ben-Num A, Cohen R (1983) Immunospecific inhibition of nerve conduction by T-lymphocytes reactive to basis protein of myelin. Nature 303:246–247

    Google Scholar 

  41. Yokota S, Gtppert TD, Lypsky PE (1988) Enhancement of antigen and mitogen-induced human T-lymphocyte proliferation by tumor necrotic factor. J Immunol 140:531–536

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First City Hospital, Department of Neurology and Neurosurgery, Russian State Medical University, Leninsky pr. 8, block 8, 117049, Moscow, Russia

    E. I. Gusev, T. L. Demina & A. N. Boiko

  2. Institute of Immunology, Moscow, Russia

    B. V. Pinegin

Authors
  1. E. I. Gusev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. L. Demina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. N. Boiko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. V. Pinegin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gusev, E.I., Demina, T.L., Boiko, A.N. et al. Prolonged dynamic clinico-immunological observation of 85 patients with definite multiple sclerosis: First steps towards monitoring process activity. J Neurol 241, 500–510 (1994). https://doi.org/10.1007/BF00919713

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00919713

Key words

Search

Navigation